• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Medicines

Medicines

  1. The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing ORION-1 Phase 2 Study of Inclisiran (formerly, PCSK9si)

    The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing ORION-1 Phase 2 Study of Inclisiran (formerly, PCSK9si)

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.